Increased rate of suicide among patients with Huntington's disease.
about
Huntington's disease geneticsSuicide risk in Huntington's diseaseSuicide screening in schools, primary care and emergency departmentsCharacterization of a large group of individuals with huntington disease and their relatives enrolled in the COHORT study.CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion.A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease.Neural bases of dysphoria in early Huntington's disease.Causes of death in patients with Huntington's disease and in unaffected first degree relativesHuntington's disease: pathogenesis, diagnosis and treatmentQuantification of age-dependent somatic CAG repeat instability in Hdh CAG knock-in mice reveals different expansion dynamics in striatum and liverChorea and related disorders.Synthesis of research and evidence on factors affecting the desire of terminally ill or seriously chronically ill persons to hasten death.Neuropsychiatry of the basal ganglia.Prevention of suicide.Suicidal behaviour in people with HIV/AIDS: a review.Dominant effects of the Huntington's disease HTT CAG repeat length are captured in gene-expression data sets by a continuous analysis mathematical modeling strategyIs Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases?Maternal factors in onset of Huntington disease.Neuropsychiatry of Huntington's disease.Suicidal behavior in prodromal Huntington diseaseDifferential effects of the Huntington's disease CAG mutation in striatum and cerebellum are quantitative not qualitative.Sequence-Level Analysis of the Major European Huntington Disease Haplotype.The Spectrum of Psychiatric Pathology in a Patient with Genetically Verified Huntington's Disease.The Genetic Modifiers of Motor OnsetAge (GeM MOA) Website: Genome-wide Association Analysis for Genetic Modifiers of Huntington's Disease.Huntington's disease. Part 1: essential background and management.The neuropsychiatry of hyperkinetic movement disorders: insights from neuroimaging into the neural circuit bases of dysfunction.Suicide in the medical settingSafety and Efficacy of Tetrabenazine and Use of Concomitant Medications During Long-Term, Open-Label Treatment of Chorea Associated with Huntington's and Other Diseases.Emerging drug therapies in Huntington's disease.Suicidal Behavior and Neurological Illnesses.The clinical and genetic features of Huntington disease.A review of Huntington's disease.Advancing pharmacotherapy for treating Huntington's disease: a review of the existing literature.Epidemiological Study of Huntington's Disease in the Province of Ferrara, Italy.Suicidality in Huntington's Disease: A Qualitative Study on Coping Styles and Support Strategies.Huntington's disease: update and review of neuropsychiatric aspects.Predictive testing for Huntington's disease: protocol of the UK Huntington's Prediction Consortium.Ethics of predictive testing for Huntington's chorea: the need for more information.Lithium Treatment in Patients With Huntington's Disease and Suicidal Behavior.Accounts of suicidality in the Huntington disease community.
P2860
Q22305906-F85D4AA0-2D13-48B3-A95D-4D11A800E387Q22306512-D3581E6B-C30F-453D-A502-B3C31C266290Q24601911-1B1CE7E5-03C4-497F-A531-11C0FCB904CFQ28732051-D9B6BBBD-9109-48F2-94CA-B76806A9169CQ30422005-DF745F10-BB4E-4F86-B605-892D931BB02BQ30446969-815EA3F8-659C-4DAD-ACB5-E8C180D316ADQ31139428-3A08E593-5063-42C9-9D50-A69189D3A87DQ33594807-26FE3E50-5BD5-4F00-9121-965F98326755Q33921449-3367C390-00FE-4A5B-9A77-14BF81A064B4Q34012758-D801DB0F-CFD8-446D-A32A-805A8D014232Q34346879-F8BE2D31-2345-4980-8A5E-534979316218Q34412554-07A27B7C-DE43-48D1-836D-5E09995FD55BQ34489109-373E4AB2-6ECA-4218-8B74-FB4FB0662D33Q34579019-72CF1B9E-8F16-4A5C-AC77-66DAE53D74FDQ34625060-5D17CC39-0024-4C70-B3CD-0ABE39C1FD7EQ34675885-68DCE885-36D6-4A21-ABDF-A9953CA5BF26Q35158376-415F6A16-60C6-4EDA-95E1-82B390C54879Q35200310-241E84B7-358D-4ADD-8FD1-A9FB36D39834Q35236937-66140317-F736-4764-95FA-38EA1997C3E0Q35268087-BB7C5413-44F1-4FCC-AF85-D7AE7933D327Q35288349-B88E5860-C7AC-4F6C-A30E-44CD5437B5BCQ36045312-B92706E7-1CE2-4F1F-A86A-E7F9BA50616FQ36106163-B667921B-42F7-4A7E-AC31-7A36BDAD737BQ36579812-FA3BC41C-9E86-4F36-BE08-B3DC6F9D49EAQ37139088-F4C500D1-7007-4D26-961C-A3FBEC430F64Q37139529-43F14582-B929-4CAA-972F-E8E05B95FFB1Q37188067-5FE63928-4586-47C9-9FF9-72497C019B8DQ37292551-62A3EB5E-246B-4B94-9A6F-C802886769ACQ37488273-4B98571E-7E2A-481C-A5B1-7C8F2EF9700AQ37541970-275A2E61-3588-4089-B538-C97873744938Q37798079-6525379C-24E3-469C-AA2F-FD82DDE744C0Q38220843-88436C74-6545-4C7B-8B0E-EF738D53E7A8Q38624994-EA58F8CF-C428-4536-92E4-3B09A04B30A4Q38627343-D512DCC5-4389-4A71-A6D6-E362567EC00EQ38858557-1406BC1F-5C70-4B45-AFEB-12909C725F80Q40612866-3FA3D544-7673-4102-A4FB-9E93DECFC1B0Q41645235-5823A600-850F-402C-9FC6-8471C7581DE1Q41902525-7DF0BBF8-DED1-4818-B5DF-588B2558E4F2Q45289251-50E9BDFE-31CC-45E9-BD9F-7CB6E9113081Q45290516-EDC1E3E5-0BC8-4947-AB10-9E17E61891D4
P2860
Increased rate of suicide among patients with Huntington's disease.
description
1984 nî lūn-bûn
@nan
1984 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
name
Increased rate of suicide among patients with Huntington's disease.
@ast
Increased rate of suicide among patients with Huntington's disease.
@en
type
label
Increased rate of suicide among patients with Huntington's disease.
@ast
Increased rate of suicide among patients with Huntington's disease.
@en
prefLabel
Increased rate of suicide among patients with Huntington's disease.
@ast
Increased rate of suicide among patients with Huntington's disease.
@en
P2093
P2860
P921
P356
P1476
Increased rate of suicide among patients with Huntington's disease.
@en
P2093
P2860
P304
P356
10.1136/JNNP.47.12.1283
P407
P577
1984-12-01T00:00:00Z